Perfromance Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Buy
3,003
+4
+0.1% +$1.43K 0.03% 83
2025
Q4
$982K Sell
2,999
-33
-1% -$10.5K 0.03% 79
2025
Q3
$856K Sell
3,032
-115
-4% -$33.4K 0.02% 86
2025
Q2
$879K Sell
3,147
-39
-1% -$11K 0.03% 76
2025
Q1
$993K Sell
3,186
-1,635
-34% -$483K 0.04% 63
2024
Q4
$1.26M Sell
4,821
-1,615
-25% -$479K 0.04% 59
2024
Q3
$2.07M Buy
6,436
+4,301
+201% +$1.41M 0.07% 46
2024
Q2
$667K Sell
2,135
-27,604
-93% -$8.11M 0.02% 71
2024
Q1
$8.46M Sell
29,739
-154
-0.5% -$45.1K 0.35% 21
2023
Q4
$8.61M Sell
29,893
-399
-1% -$109K 0.38% 22
2023
Q3
$8.14M Buy
30,292
+1,068
+4% +$267K 0.4% 24
2023
Q2
$6.6M Buy
29,224
+253
+0.9% +$58.7K 0.3% 28
2023
Q1
$7M Buy
28,971
+1,939
+7% +$476K 0.36% 26
2022
Q4
$7.1M Buy
27,032
+57
+0.2% +$15.3K 0.43% 26
2022
Q3
$6.08M Sell
26,975
-504
-2% -$122K 0.35% 28
2022
Q2
$6.69M Sell
27,479
-990
-3% -$243K 0.38% 29
2022
Q1
$6.88M Sell
28,469
-2,814
-9% -$647K 0.3% 31
2021
Q4
$7.04M Buy
+31,283
New +$6.6M 0.28% 36

Other funds holding AMGN

Perfromance Wealth Partners's AMGN Position: Q1 2026 in Review

Perfromance Wealth Partners increased its Amgen (AMGN) stake by 0.13% in Q1 2026, buying an estimated $1.43K and bringing the position to 3,003 shares worth $1.06M. The position accounts for 0.03% of the portfolio, ranked #83.

Perfromance Wealth Partners first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.61M in Q4 2023. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Perfromance Wealth Partners held 3,003 shares of Amgen worth $1.06M as of Q1 2026.
  • Perfromance Wealth Partners bought 4 Amgen shares in Q1 2026, an estimated $1.43K.
  • Amgen made up 0.03% of Perfromance Wealth Partners's portfolio in Q1 2026, its #83 holding.
  • Perfromance Wealth Partners first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • Perfromance Wealth Partners's Amgen position peaked at $8.61M in Q4 2023.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Perfromance Wealth Partners's 13F filing for Q1 2026, filed 10 Apr 2026.